Prior to testing efficacy of siRNA-mediated CTNNB1 knockdown in HCC, we assessed whether there were any effects of the LNP itself on the tumor immune microenvironment (TIME). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.